- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (5)
8 result(s) found for: Dandruff.
Displaying page 1 of 1.
EudraCT Number: 2011-000852-40 | Sponsor Protocol Number: TBSH-01 | Start Date*: 2012-08-03 | ||||||||||||||||
Sponsor Name:Dermal Laboratories | ||||||||||||||||||
Full Title: A double-blind, placebo-controlled study determining the efficacy of terbinafine shampoo in the treatment of pityriasis capitis and seborrhoeic dermatitis. | ||||||||||||||||||
Medical condition: The two severe dandruff conditions to be investigated in this study are pityriasis capitis and seborrhoeic dermatitis. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-005085-21 | Sponsor Protocol Number: KCSA-03 | Start Date*: 2005-12-13 |
Sponsor Name:Dermal Laboratories Limited | ||
Full Title: Scalp lotion for the treatment of pityriasis capitis (severe dandruff) and seborrhoeic dermatitis. | ||
Medical condition: Seborrhoeic dermatitis and pityriasis capitis of the scalp. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-005242-36 | Sponsor Protocol Number: K40-3 | Start Date*: 2006-12-13 | |||||||||||
Sponsor Name:Moberg Derma AB | |||||||||||||
Full Title: A multicenter, randomised, double-blind, placebo-controlled clinical study evaluating efficacy, safety and tolerability of topical K40 in 8 weeks treatment of adult patients with moderate to severe... | |||||||||||||
Medical condition: Seborrhoeic Dermatitis of the scalp. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006188-59 | Sponsor Protocol Number: K301-1 | Start Date*: 2008-01-14 | |||||||||||
Sponsor Name:Moberg Derma AB | |||||||||||||
Full Title: A multicenter, randomised double blind, placebo-controlled study of efficacy, safety and tolerability of Kaprolac® K301 for the treatment of seborrhoeic eczema (SE) of the scalp. | |||||||||||||
Medical condition: seborrhoeic dermatitis of the scalp | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005795-13 | Sponsor Protocol Number: Ketoil 01/07 | Start Date*: 2007-11-12 | |||||||||||
Sponsor Name:MIPHARM | |||||||||||||
Full Title: EFFICACY AND SAFETY ASSESSMENT OF KETOIL, SHAMPOO CONTAINING KETOCONAZOLE 0.5% SERENOA REPENS (SAW PALM) AND TAURINE, IN THE TREATMENT OF PATIENTS AFFECTED BY DANDRUFF AND SEBORRHEIC DERMATITIS COM... | |||||||||||||
Medical condition: dandruff and seborroic dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013276-46 | Sponsor Protocol Number: N/A | Start Date*: 2010-02-05 |
Sponsor Name:Queen Victoria Hospital | ||
Full Title: The effect of oral Ivermectin on Demodex associated blepharitis | ||
Medical condition: Demodex Follicularum associated anterior blepharitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007088-25 | Sponsor Protocol Number: V00071 GM 201 1A | Start Date*: 2008-04-15 |
Sponsor Name:Pierre Fabre Dermatologie | ||
Full Title: Efficacy and tolerance of V0071 GM 01A in inflammatory seborrhoeic dermatitis of the scalp. | ||
Medical condition: Inflammatory seborrhoeic dermatitis of the scalp in adult | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000292-15 | Sponsor Protocol Number: S241-GB-10 | Start Date*: 2006-03-13 | |||||||||||
Sponsor Name:Stiefel Laboratories Maidenhead Ltd. | |||||||||||||
Full Title: A Phase II, Single-Centre, Randomised,Double-Blind, Parallel Group, CPO Solution, Dose Range Finding Study in Subjects with Seborrhoeic Dermatitis of the Scalp | |||||||||||||
Medical condition: Seborrhoeic dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
